Status:
COMPLETED
Smoking Cessation in Patients With COPD (SMOCC) in General Practice
Lead Sponsor:
ZonMw: The Netherlands Organisation for Health Research and Development
Collaborating Sponsors:
The Netherlands Asthma Foundation
Pharmacia
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility:
All Genders
35+ years
Phase:
PHASE4
Brief Summary
Background: Smoking cessation is the key element in the treatment of patients with Chronic Obstructive Pulmonary Disease (COPD). The role of the general practice in assisting these patients with succe...
Eligibility Criteria
Inclusion
- A software program using Anatomical Therapeutical Chemical (ATC) prescription codes and International Classification of Primary Care (ICPC) diagnosis codes selected potential patients with COPD. Criteria: age \>35 years and a diagnosis recorded as COPD or as ICPC code R95/96, or a prescription of at least three times of bronchodilators (ATC code R03a/bc) and/or prescription of at least two times of inhaled anti-inflammatory medication in the past year (ATC code R03). General practitioners (GPs) had to confirm the diagnosis of the selection. Patients were eligible to participate if they met the following criteria:
- Current smoking
- Suffering from COPD according to the GP's diagnosis
- In command of the Dutch language.
Exclusion
- Too ill
- Under control of a chest physician
- Serious physical or psychological comorbidity
Key Trial Info
Start Date :
March 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2003
Estimated Enrollment :
667 Patients enrolled
Trial Details
Trial ID
NCT00628225
Start Date
March 1 2000
End Date
December 1 2003
Last Update
October 17 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud University Nijmegen Medical Centre
Nijmegen, Netherlands, 6500HB